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Summary

Chrondroitin sulphate proteoglycans obtained from
embryonic chick bone marrow and epiphyseal cartilage were compared using immunochemical and
biochemical analyses. Proteoglycans from each tissue, separated on CsCl density gradients, under
dissociative conditions, into high (l^gml" 1 ), medium (l-Sgml" 1 ) and low (l-4gml~') buoyant density fractions, were immunochemically analysed,
using a panel of monoclonal antibodies that specifically recognize chondroitin 4-/dermatan sulphates,
chondroitin 6-sulphate, keratan sulphate, the hyaluronate binding region present on connective tissue proteoglycans, and link protein. The same
antibodies were used in Western blot analyses to
detect intact proteoglycan monomers and core proteins that had been fractionated by agarose-polyacrylamide and by sodium dodecyl sulphate-polyacrylamide gel electrophoresis. Specific differences
between marrow and cartilage proteoglycans were
detected. In CsCl gradients, marrow proteoglycans
displayed a higher degree of heterogeneity in terms
of buoyant densities and hexuronate distribution.

Keratan sulphate chains were constituents of the
majority of 'large' proteoglycans in the marrow;
however, a portion of the large proteoglycans in
marrow middle buoyant density fraction either
lacked keratan sulphate chains or were substituted
with a form different from that found on cartilage
proteoglycans. Marrow lacked 'small' chondroitin/
dermatan sulphate proteoglycans that were present
in cartilage and contained a more heterogeneous
population of proteoglycans, particularly in the
lower buoyant density fractions. Both marrow and
cartilage were similar in that they contained, as
their major components, large, aggregating proteoglycans and link proteins that were immunochemically and biochemically identical. The significance
of these differences between marrow and cartilage
proteoglycans remains to be determined, but they
may, in part, be responsible for imparting unique
characteristics to the haematopoietic extracellular
matrices.

Introduction

amounts and relative compositions of these proteoglycans
have been shown to vary according to haematopoietic
status (Noordegraaf & Ploemacher, 1979; Noordegraaf &
Ploemacher, 1980; Noordegraaf et al. 1981). Gallagher et
al. (1983) provided clear evidence for differences between proteoglycans associated with stromal cells and
proteoglycans released into the medium in long-term
haematopoietic cultures. Cell-associated proteoglycans
were enriched in heparan sulphate and also contained
some chondroitin sulphate, whereas those released into
the medium consisted almost entirely of chondroitin
sulphates. This work was confirmed and extended by
Wight et al. (1986), who have also provided important
information concerning the nature of intact proteoglycan
molecules in haematopoietic cultures. All previous

The concept of a haematopoietic inductive microenvironment was first postulated by Trentin and his colleagues
(Curry & Trentin, 1967; Curry et al. 1967; Trentin,
1978). Since then, it has become increasingly evident that
non-haematopoietic stromal cells are largely responsible
for generating this environment (Dexter, 1982). Stromal
cells appear, in large part, to be responsible for elaborating an extracellular matrix milieu that may be critical for
haematopoietic—stromal cell interactions (Spooncere< al.
1983; Zuckerman & Wicha, 1983; Zipori et al. 1985).
A diverse group of molecules, proteoglycans (Hascall
& Hascall, 1981; Hassell et al. 1986), are a major
component of hematopoietic extracellular matrices. The
Journal of Cell Science 91, 81-90 (1988)
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Table 1. Monoclonal antibodies used for this study and their epitopes
Epitope

Antibody
2B6
3B3
5D4
1C6
8A4

Dclta-unsaturated 4-sulphated epitope generated by chondroitinase
ABC digestion of chondroitin 4-/dermatan sulphates
Delta-unsaturated 6-sulphated epitope generated by chondroitinase
ABC digestion of chondroitin 6-sulphate
Linear, sulphated heptasacchande, or larger, of poly-.Vacetyllactosamine (keratan sulphate)
Hyaluronatc binding region of core proteins after reduction and
alkylation
Link protein

studies were limited to the nature of the glycosaminoglycan chains.
The importance of studying intact proteoglycan molecules has been emphasized by recent studies that implicate tissue-specific proteoglycans with the ability to
sequester growth factors selectively (Okai, 1985; Gordon
et al. 1987; Vlodavsky et al. 1987). Sequestration and
concentration of growth factors on surfaces of stromal
cells would account, in part, for the difficulties in
recovering haematopoietic growth factors from long-term
marrow cultures (Dexter et al. 1977; Williams etal. 1977)
and might, in part, account for the apparent requirement
for close cell-to-cell contact between haematopoietic and
stromal cells (Dexter, 1982; Bentley, 1981).
In the present study, embryonic chick marrow chondroitin sulphate proteoglycans were characterized and
compared with embryonic chick cartilage proteoglycans,
about which considerable information has accumulated
(Kimata et al. 1974; Vasan & Lash, 1978; Noro et al.
1983; Shinomura et al. 1983; Carrino & Caplan, 1985).
Well-characterized monoclonal antibodies that specifically recognize chondroitin 4-sulphate and dermatan
sulphate (2B6), chondroitin 6-sulphate (3B3), and keratan sulphate (5D4) chains were used to identify GAG
chains and to immunolocate proteoglycans on Western
blots after composite agarose-polyacrylamide gel electrophoresis of intact monomers and sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE)
analyses of core proteins (Caterson et al. 1983, 1985,
1986, 1987). Monoclonal antibody 1C6, which specifically recognizes the hyaluronate binding region, was used
to identify chondroitin sulphate proteoglycans that have
the potential to form aggregates (Stevens et al. 1984;
Caterson et al. 1986, 1987), while antibody 8A4 was used
to identify link protein (Caterson et al. 1986), also a
component of macromolecular aggregates (Hay, 1981).
These methods provided a highly sensitive means of
examining the total proteoglycan composition of these
tissues, not merely the newly synthesized pool obtained
after metabolic labelling with radioactive tracers.
A heterogeneous population of marrow chondroitin
sulphate proteoglycans was identified, many of which
were nearly identical to cartilage proteoglycans. However, comparative studies indicated specific differences in
two of the three proteoglycan fractions. These results
target chondroitin sulphate proteoglycan species that may
be marrow-specific.
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Materials and methods
Antibodies
All monoclonal antibodies used in these studies had specificities
directed against different components of chondroitin sulphate
proteoglycans. See Table 1 for details concerning epitopes
recognized by these monoclonal antibodies.

Extraction and buoyant density fractionation of
proteoglycans
Femora and tibiae were dissected from cold anaesthetized day
17 chick embryos (75 embryos per experiment) and stripped of
soft tissue. The epiphyseal cartilages were removed and the
bones cut lengthwise in half. Marrow was scraped from the
bones directly into cold 4M-guanidine- HC1 containing protease
inhibitors (Sajdera & Hascall, 1969). After all marrow had been
removed, excess guanidine-HC1 was added so that the final
volume was at least 20 times that of marrow. This was stirred
continuously for 24 h at 4°C, centrifuged at 15 OOOg'for 30min,
and the supernatants were collected. Solid CsCI was added to
give a density of l-5gml~'. After centrifugation at lOOOOOgat
10°C for 48 h under 'dissociative' conditions (Oegema el al.
1975), the bottom (MD1 or CD1), middle (MD2 or CD2) and
top (MD3 or CD3) thirds of the CsCI density gradients from
the marrow or cartilage extracts, respectively, were carefully
collected and small samples were taken for density and hexuronate analysis (Carney et al. 1986). Each fraction was dialysed
exhaustively against 015M-NaCl and then distilled water. Dry
weights were determined and samples stored as lyophilized
powder.

Dot-blot analysis
Marrow and cartilage proteoglycans from each fraction were
dissolved in 4M-guanidine-HC1, 0-001 M-EDTA, OlM-Trisacetate, pH 8 0 , to give a concentration of 1 m g m F 1 . Samples
were divided in half: one part was treated with 0-065Mdithiothreitol for 4h at 50 c C (reduced), the other part was
incubated at 50°C without dithiothreitol (native). Both portions
were treated with 016M-iodoacetic acid in the dark at room
temperature for 20min then dialysed against three changes of
phosphate-buffered saline containing azide (PBS-AZ) over a 24h period (Stevens et al. 1984).
Native and reduced and alkylated samples were applied by
vacuum suction to same sheet of nitrocellulose using a
Schleicher and Scheull Minifold apparatus (Caterson et al.
1987). All nitrocellulose sheets were incubated in 5 % bovine
serum albumin (BSA) at room temperature for 1 h and then
incubated with 001 unit ml" 1 of chondroitinase ABC prior to
immunolocation. Each monoclonal antibody was diluted 1/100
in 5 % BSA in 0-1 M-Tris-saline and was incubated with antigen
on nitrocellulose sheets for 90min at room temperature. The
first antibody incubation step was eliminated for control

Table 2. Dry weight and hexumnate profiles or pmteoglycans obtained fwm CsCI dissociative gradients
Fraction

Density*

Hcxuronatc

% Totalf
dry weight

Hexuronatc/
dry wcight§

Marrow
MD3
MD2
MD1

1-4
1-5
1-6

16
28
56

68
16
16

0-022
0-166
0-281

Cartilage
CD3
CD2
CDI

14
1-5
1-6

7
18
75

28
16
56

0039
0-235
0-273

All data represent the averages obtained from three separate fractionation procedures.
• Density is expressed in units of gml '.
•f Hexuronatc was determined by the method of Bitter & Muir (1962).
X Dry weights were determined after lyophilization.
§ The hexuronate content of each fraction expressed in mg was divided by the dry weight of each fraction expressed in mg.

samples. After washing three times with Tris-saline, peroxidase-conjugated goat anti-mouse second antibody diluted 1/500
was incubated with each sheet. After washing with Tris-saline,
4-chloro-l-naphthol and H2O2 substrate was added and
coloured precipitating products developed. The reaction was
stopped by washing with PBS-AZ. The nitrocellulose sheets
were air-dried prior to photographic reproduction.

antibodies. As a negative control, the first antibody incubation
step was eliminated for one set of samples.
Western blot analysis of link protein was performed as
described above, except that antibody 8A4 was used for
immunolocation after 10% SDS-PAGE analyses of the MD3
and CD3 fractions.

Results
Fraclionation of intact proteoglycan monomers on
composite agarose-polyacrylamide gels
Composite agarose-polyacrylamide gels were run using a modified method described by Carney et al. (1986). Agarose (0-6%
final concentration) was suspended in gel buffer (0-04 MTris-acetate/0-001 M-Na2SO4, pH 6-8) and heated to 90°C
with constant stirring. This mixture was allowed to cool to 50°C
before adding acrylamide/bisacrylamide (1-2% final concentration). The final mixture was poured into preheated (50°C)
slab gel plates and allowed to set at 4CC for 1 h. Plates were
equilibrated overnight in 4M-urea and gel buffer (Carney et al.
1986). Samples dissolved in 8M-urea were applied to the gel and
electrophoresed at constant voltage for 2 h until the tracking dye
had migrated 3-4cm. Some gels were stained with 0-02%
Toluidine Blue to reveal proteoglycans. Samples from other
gels were immunolocated after transfer onto nitrocellulose (see
dot-blot procedures). Enzyme digestion, when needed, was
performed on nitrocellulose-bound samples prior to immunolocation. The first antibody incubation step was omitted for one
set of samples as a negative control. All immunolocation studies
were performed on parallel set of samples, one digested with
chondroitinase ABC while bound to the nitrocellulose, the
other remaining undigested. Canine articular cartilage proteoglycan (a gift from S. Carney, Kennedy Institute, London) was
used as a standard in these analyses.

Fractionation of proteoglycan core proteins by sodium
dodecyl sulphate-polyacrylamide gel electrophoresis
Lyophilized marrow fractions were dissolved in distilled water
to make a I m g n i l " ' solution. Chondroitinase ABC, 005
unitml" 1 in 0 1 M-Tris-acetate, p H 8 0 , was added and the
samples were incubated for 1 h at 37°C. Samples were boiled for
5 min in the presence of 2-mercaptoethanol. Samples and
molecular weight standards were added to 5 or to 7% to 17%
gradient gels and electrophoresed at 50 mA gel" 1 while samples
were in the stacking gel, and thereafter at 35 mAgeP 1 . Western
blots were blocked and stained as described above (dot-blot
assay) using 1/100 mixture of 2B6 and 3B3 as primary

Comparison of marrow and cartilage proteoglycans
fractionated on dissociative CsCI density gradients
Proteoglycan monomers, extracted from the same day 17
embryonic chick femoral and tibial bone marrows and
epiphyseal cartilages, were compared using combined
immunochemical and biochemical analyses. Proteoglycan
monomers from both tissues were fractionated on CsCI
density gradients under dissociative conditions and three
equal portions were collected (Table 2). Marrow proteoglycans differed from cartilage proteoglycans in that a
substantially lower proportion of the total hexuronate
(56% for MD1 versus 75% for CDI) was found in the
high buoyant density (Dl) fractions and correspondingly
higher proportions of hexuronate were found in the lower
buoyant density fractions, MD2 and MD3. Marrow
contained a substantially higher proportion of extractable
material that partitioned to the low buoyant density
fraction (68 % dry weight compared to 28 % dry weight,
Table 2), indicating that marrow contained a higher
content of non-proteoglycan molecules than did cartilage.
Both Dl fractions were identical in terms of their
hexuronate to dry weight ratios and buoyant densities,
but the hexuronate to dry weight ratio of marrow fraction
MD2 was lower than that of marrow fraction MD1, as
well as cartilage fractions CDI and CD2. This implies
that MD2 proteoglycans were probably substituted with
either fewer or shorter GAG chains than those of
proteoglycans in all other Dl and D2 fractions. The
presence of partially degraded proteoglycans in marrow
might also account for this difference.
Immunochemical compansons of manvzv and cartilage
proteoglycan monomers
Epitopes recognized by three carbohydrate-specific
monoclonal antibodies (Table 1) were found in each
marrow and cartilage fraction (Fig. 1). This suggests that
Chondroitinjdermatan sulphates in marroiv
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Fig. 1. Dot-blot analysis was used to compare marrow MD3
(1), MD2 (2), MD1 (3), CD3 (4), CD2 (5), and CD1 (6)
fractions. Samples from each fraction were immunolocated
with: A, monoclonal antibody 2B6, specific for chondroitin
4-/dermatan sulphates; B, antibody 3B3, specific for
chondroitin 6-sulphate, antibody 5D4; C, specific for keratan
sulphate; D, antibody 1C6, specific for epitopes associated
with hyaluronate binding region, and, as a control; E, no first
antibody. Antigen in the top rows of each panel were
unreduced, while proteoglycans in the bottom rows were
reduced and alkylated prior to immunoanalyses.

some degree of heterogeneity existed in proteoglycan
populations from both marrow and cartilage. However,
these analyses did not indicate to what extent chondroitin 4-/dermatan sulphate chains, recognized by antibody 2B6, or chondroitin 6-sulphate chains, recognized
by antibody 3B3, were substituted to the same or to
different core proteins. Other evidence for differential
glycosaminoglycan chain substitution is presented below
(section III). Keratan sulphate epitopes, which must be
sulphated, were identified using antibody 5D4 (Mehmet
et al. 1986). These epitopes were present in all fractions
from both marrow and cartilage, although the marrow
middle buoyant density fraction (MD2) appeared to
contain relatively less of this epitope than did any of the
other fractions (Fig. 1). This indicates that proteoglycans
obtained from bone marrow were more cartilage-like than
expected.
Also shown in Table 1 are the results obtained using a
monoclonal antibody that recognizes a specific region of
core proteins, the hyaluronate binding region. Reduction
and alkylation is required to denature the core protein
and to expose the epitope to antibody 1C6. This antibody
identified epitopes in both marrow and cartilage Dl
fractions (Fig. 1). However, on the basis of the relative
intensity of dots after immunolocation, it appeared that
84
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Fig. 2. Samples from low buoyant density marrow and
cartilage fractions were analysed by SDS-PAGE, under
reducing conditions, on a 10% gel, electroblotted onto
nitrocellulose, and immunolocated using antibody 8A4,
specific for link protein. One major band, representing a
protein with an apparent molecular weight of 43X103, was
immunolocated in both marrow (lane a) and cartilage (lane b)
fractions. Also, a second band, probably representing a
second and minor link protein, was weakly immunolocated
(thin arrows) in each fraction. Marrow (lane a) contained a
faster migrating peptide (thick arrow), which was also
immunolocated by antibody 8A4.

cartilage contained a higher proportion of proteoglycans
with a hyaluronate binding region. Quantitative studies
will be needed to confirm this observation. In cartilage,
fractions from all buoyant densities contained the epitopes associated with the hyaluronate binding region. In
marrow, this epitope was primarily found in the MD1
fraction, while some epitope (but at much lower levels
than found in cartilage) was detected in the MD2
fraction, and almost no epitope was found in the MD3
fraction. Immunolocation by antibody 1C6 of components in the unreduced proteoglycan samples from the
cartilage low buoyant density fraction (CD3) could be
attributed to the presence of either proteolytically cleaved
and/or otherwise denatured components of the hyaluronate binding region (Caterson et al. 1986).
Low buoyant density fractions from both marrow and
cartilage contained one major link protein, as identified
by link protein-specific antibody 8A4 (Fig. 2). This link
protein migrated on a 10% SDS-polyacrylamide gel
with an apparent molecular weight of 43X10 3 . In addition, a minor, slightly faster migrating link protein was
present in both tissues. The marrow fraction contained a
faster migrating peptide that was also immunolocated by
antibody 8A4. These studies were repeated using several
different marrow and cartilage samples, comparing the
results both with and without mercaptoethanol reduction. The faster migrating peptide was never identified in non-reduced samples, but was identified in some

a

a

a

b

b

b

c

a

b'

4

Fig. 3. Serial dilutions of intact proteoglycans from marrow
and cartilage fractions MD1 (lanes a), CD1 (lanes b) and, as
a standard, canine femoral articular cartilage proteoglycan
monomer (lanes c) were analysed by electrophoresis on
composite agarose-polyacrylamide gels. The gel was stained
with 0-2% Toluidine Blue.

of the reduced samples. Previously, it had been shown
that reduction by mercaptoethanol was needed to identify
link protein fragments (Mort et al. 1985). Thus, it is
possible that the small peptide is a proteoglycalically
cleaved component of intact link protein. Identification
of both link protein and hyaluronate binding region is
consistent with the presence of aggregating proteoglycans
in bone marrow, which are similar to those found in
cartilage (Hascall & Hascall, 1981).
Comparison of intact chondroitin sulphate proteoglycan
monomers from marrow and cartilage using composite
aga?vse-polyacrylamide gels
Marrow and cartilage high buoyant density proteoglycans
were analysed according to their electrophoretic mobilities in composite agarose-polyacrylamide gels. Using
this procedure, the heterogeneous proteoglycan subpopulations can be separated and then analysed biochemically using immunochemical procedures (Carney et
al. 1986). In Fig. 3, marrow and cartilage proteoglycans,
along with a canine cartilage proteoglycan monomer
standard, were identified by staining the gel with Toluidine Blue. Proteoglycans from both chick tissues
migrated with similar mobilities that were slower than the
canine standard. A slower migration in composite agarose-polyacrylamide gels is usually indicative of large
chondroitin sulphate-containing proteoglycans with relatively low amounts of keratan sulphate. In both tissues
the proteoglycan bands were diffuse, consistent with a
high degree of polydispersity in size and charge.
Electrophoretic analysis on composite agarose-polyacrylamide gels was repeated, but now proteoglycans
were identified on Western blots using monoclonal antibodies 2B6 and 3B3 separately (Fig. 4). Chondroitin 6sulphate-specific antibody 3B3 identified a slower migrating subpopulation (Fig. 4, lanes a and b). In contrast,
antibody 2B6, specific for chondroitin 4-/dermatan sulphates detected a faster migrating subpopulation of
proteoglycans in both marrow and cartilage (Fig. 4, lanes
a' and b'). These data suggest that at least two subpopu-

Fig. 4. Intact proteoglycans from marrow and cartilage
fractions MD1 (lanes a and a') and CD1 (lanes b and b'), as
well as canine articular cartilage proteoglycans (lanes c and
c'), were analysed by electrophoresis on a composite
agarose-polyacrylamide gel, electroblotted onto
nitrocellulose, and immunolocated using antibody 3B3, antichondroitin 6-sulphate (lanes a, b, c); and antibody 2B6,
anti-chondroitin 4-/dermatan sulphates (lanes a', b', c'). The
nitrocellulose sheets were incubated with chondroitinase ABC
prior to immunolocation with monoclonal antibodies.

lations of proteoglycans were present in the high buoyant
density fractions: one subpopulation of proteoglycans
substituted largely with chondroitin 4-/dermatan sulphate and a second subpopulation substituted largely
with chondroitin 6-sulphate. However, the existence of a
population of proteoglycans substituted by multiple types
of glycosaminoglycan chains cannot be totally excluded.
The migration patterns of the intact monomers suggest
that chick Dl proteoglycan monomers are large; however, mobilities can also be affected by ionic charge. In
order to confirm that these monomers were in fact large
proteoglycans, the sizes of core proteins were determined.
Comparison of marrow and cartilage proteoglycan core
proteins by SDS—PAGE after removal of chondroitin
sulphate GAG chains by chondroitinase ABC
The core proteins, generated by digestion with chondroitinase ABC, from each marrow and cartilage fraction,
were analysed by SDS-PAGE on 5 % slab gels under
reducing conditions (Fig. 5). Samples from fractions
MD1 (lane a), CD1 (lane b), MD2 (lane c) and CD2
(lane d), detected on a Western blot by a mixture of
antibodies 2B6 and 3B3, remained either in the stacking
gel or just entered the top of the running gel, indicating
that they were large molecules with apparent molecular
weights in excess of 212X103 (Fig. 5). This means that all
proteoglycan fractions analysed on this gel have large core
proteins and can be considered as belonging to the class of
large proteoglycans (Heinegard et al. 1985; Hassell et al.
1986). It was not possible, on the basis of these results, to
determine whether these large proteoglycans found in
marrow and cartilage were exactly equivalent in size,
Chondroitin/dermatan sulphates in marrow
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4743Fig. 5. Proteoglycan core protein derived from
chondroitinase ABC-digested marrow and cartilage fractions
MD1 (lane a), CD1 (lane b), MD2 (lane c), CD2 (lane d),
MD3 (lane e), and CD3 (lane f) were analysed by
SDS-PAGE on a 5 % gel, electroblotted onto nitrocellulose,
and immunolocated with a mixture of monoclonal antibodies
2B6 and 3B3. Molecular weight markers for 212 and
97(XlO 3 ),l/ r are indicated. Arrowheads in lane e indicate
three pairs of bands immunodetected in the MD3 fraction,
while the arrowhead in lane f indicates the single band
immunodetected in the CD3 fraction.

since these molecules were not effectively resolved in the
running gel. Small proteoglycan core proteins with
apparent molecular weights of 43 and 47(X 103) were also
immunochemically identified in cartilage D2 fractions
after electrophoresis on a 7 % to 17 % linear gradient
SDS-polyacrylamide gel, but similar core proteins were,
not detected in the equivalent marrow fraction
(Fig. 6A,B), thus indicating a difference in the proteoglycan compositions of these two tissues.
Intermediate-sized core proteins, migrating with apparent molecular weights ranging from 100 to 200(X 10 ),
were detected on a Western blot using a mixture of
antibodies 2B6 and 3B3 (Fig. 5, lanes e and f). Multiple
bands were detected in the marrow fraction MD3 (lane
e). In contrast, only one such band, with an apparent
molecular weight of 120X103 and corresponding to the
second fastest migrating MD3 band, was identified in the
cartilage fraction CD3 (lane f). It is likely that some or
possibly all of the proteoglycan core proteins identified in
the low buoyant density fractions represented partial
degradation products of large proteoglycans.
Comparative dot-blot immunoanalyses of marrow and
cartilage fractions (Fig. 1) revealed the presence of
keratan sulphate epitopes, using antibody 5D4, in both
marrow and cartilage proteoglycans. As noted above, the
MD2 fraction contained relatively less of this epitope
than did any other marrow or cartilage fractions. The low
level of keratan sulphate substitution of the MD2 fraction
was further confirmed on Western blots (Fig. 7). Anti86
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Fig. 6. Proteoglycan core protein derived from
chondroitinase ABC-digested marrow and cartilage fractions
MD2 (lane a) and CD2 (lane b) were analysed by
SDS-PAGE on a 7 % to 17 % linear gradient gel,
electroblotted onto nitrocellulose, and immunolocated with a
mixture of monoclonal antibodies 2B6 and 3B3. Arrowheads
indicate 43 and 47(X1O3)/Wr bands in CD2 fractions.

body 5D4 immunolocated epitopes in both marrow (lane
a) and cartilage (lane b) high buoyant density fractions,
but failed to identify epitopes in the marrow middle
density fraction (lane c), although epitopes were identified in the CD2 fraction (lane d). The discrepancy

212

Fig. 7. Proteoglycan core protein derived from
chondroitinase ABC-digested marrow and cartilage fractions
MD1 (lane a), CD1 (lane b), MD2 (lane c), and CD2 (lane
d) were analysed by SDS-PAGE on a 5 % gel, electroblotted
onto nitrocellulose, and immunolocated with monoclonal
antibody 5D4, specific for keratan sulphate. The 212xl0JyWr
marker is indicated.

between these results and those shown in Fig. 1 are
probably related to the lower sensitivity of Western blot
analyses compared with that of dot-blot analyses. Repetition of these studies using the same and different keratan
sulphate-specific antibodies produced the same results as
those indicated above. These results indicate that some of
the marrow proteoglycans differ, in terms of their constituent glycosaminoglycan chains, from cartilage proteoglycans.

Discussion
The present data indicate that, while there was a high
degree of similarity between chick marrow and cartilage
proteoglycans, diversity also existed. Several specific
differences between marrow and cartilage proteoglycans
were noted. (1) In marrow, proteoglycan monomers
appeared to display a higher degree of heterogeneity. A
substantially higher proportion of proteoglycans resided
in the middle and low buoyant density fractions. (2)
Marrow middle buoyant density proteoglycans were
substituted with either less or a different form of keratan
sulphate. (3) Small proteoglycans, characteristic of cartilage, bone, and some other non-cartilaginous tissues
(ShinomuraeJ al. 1983; Hassell et al. 1986), appeared to
be absent from marrow. (4) Finally, marrow contained
what appeared to be a heterogeneous population of
proteoglycans in the low buoyant density fraction that
were not detected in the equivalent cartilage fraction.
Marrow from chick embryos contained large chondroitin sulphate proteoglycan monomers, which possessed large core proteins similar in size to those found in
cartilage. Nonetheless, marrow proteoglycans apportioned differently from cartilage proteoglycans on
dissociative CsCl gradients. Marrow contained a substantially higher proportion of intermediate and low buoyant
density proteoglycans. This suggested that differences in
glycosylation and/or sulphation patterns might have
existed between some of the marrow and cartilage proteoglycans. Partial degradation of proteoglycans would also
result in smaller sizes and lower buoyant densities.
Hence, differences in endogenous turnover of proteoglycan could affect the partitioning of proteoglycans on CsCl
gradients.
A high proportion of marrow proteoglycans were
cartilage-like in terms of their large size, presence of an
epitope associated with the hyaluronate binding region,
and substitution with keratan sulphate. Nevertheless,
some of the marrow proteoglycans, particularly those in
the MD2 fraction, differed from cartilage proteoglycans
in regard to keratan sulphate substitution. Antibody 5D4
provided a weak immunolocalization of MD2 when the
more sensitive dot-blot assay was used, and failed to
identify epitopes on MD2 on less-sensitive Western blots
after SDS-PAGE fractionation. These data suggest that
relatively little keratan sulphate was associated with
marrow MD2 proteoglycans. Alternatively, they suggest
that keratan sulphate, if present, did not contain epitopes
that were readily recognized by antibody 5D4. Chemical
desulphation of keratan sulphate chains reduced anti-

genicity for this antibody (Mehmet et al. 1986; Funderburgh et al. 1987). Thus, low sulphated keratan sulphate
might be present on some marrow proteoglycans, particularly those in the MD2 fraction, and this might
account for the weak immunochemical reactivity of
antibody 5D4. Marrow also differed from cartilage in that
small chondroitin sulphate proteoglycans were absent, or
at least undetected, by the methods used in this study.
Small proteoglycans, with core proteins of 43 and
47(xlO3)jV/r, as assessed by SDS-PAGE, have been
identified in cartilages obtained from a variety of vertebrate species, including those from embryonic chicks
(Shinomura et al. 1983; Hassell et al. 1986). It was
unlikely that this was due to procedural problems, since
two core proteins with apparent molecular weights of 43
and 47X103 were detected in the CD2 fraction. Small
proteoglycans, usually substituted with dermatan sulphate chains, are not entirely restricted to cartilages
(Hassell et al. 1986). Wight et al. (1986) identified, as a
minor species, a small dermatan sulphate proteoglycan
produced by long-term cultures of human marrow.
These 'small' proteoglycans, in a variety of tissues, often
appear to be closely associated with collagen types I and
III (Hassell et al. 1986). The relative sparsity of such
collagens in embryonic chick marrow might account for
the absence of small proteoglycans in chick marrow
(Sorrell <?f a/. 1987).
Marrow, but not cartilage, contained an apparently
heterogeneous population of proteoglycans in the low
buoyant density fraction. At least six core proteins were
detected on Western blots of marrow D3 proteoglycans
that had been fractionated by SDS-PAGE. The apparent molecular weights of marrow core proteins ranged
from 100 to 200(Xl0 3 )A/ r in marrow, compared to only
one core protein, of about 120xl0 3 A7 r , in cartilage.
These putative, intermediate-sized proteoglycans have
yet to be identified definitively. At present two possibilities exist: one or more bands in the MD3 fraction
might represent the core protein(s) of a uniquely different proteoglycan; on the other hand, these might be
partially degradation products of large core protein(s),
those larger than 212x 10 3 M r . Both marrow and cartilage
proteoglycans were extracted simultaneously in the same
media containing protease inhibitors. Multiple bands
were absent from the equivalent cartilage fraction (a
tentative identification can be made for the one band in
the CD3 fraction, see below). Thus, it is unlikely that
degradation, if it existed, could be attributed to the
extraction procedures. Rather, if degradation occurred, it
is more likely to be a consequence of higher endogenous
turnover of marrow proteoglycans.
Proteoglycans comprise a diverse group of molecules
(Hassell et al. 1986). Nevertheless, this diversity is
limited. Therefore, it is not surprising that similarities
among marrow and cartilage proteoglycans exist. Wight
et al. (1986) also commented on the overall similarity of
proteoglycans obtained from long-term human marrow
cultures to proteoglycans obtained from aorta, and in this
study, similarities among chick marrow and cartilage
proteoglycans were clearly evident. As with cartilage,
most marrow proteoglycans belong to a family of large
Chondroitin/dermatan sulphates in marrow
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proteoglyeans (Heinegard et al. 1985; Hassell et al.
1986), some of which, particularly those in the high
buoyant density fraction, contained a hyaluronate binding region. This implies that these proteoglyeans are
capable of associating with hyaluronic acid to form
macromolecular aggregates (Hascall & Hascall, 1981).
Further evidence for the presence of proteoglycan aggregates was provided by the immunodetection of link
protein, also known to be a component of macromolecular aggregates (Hay, 1981). Similar proteoglycans have
been identified in a wide variety of non-cartilaginous
tissues and cultured fibroblastic cell lines (Norling et al.
1978; McMurtrey et al. 1979; Wagner et al. 1983;
Schafere* al. 1984; Heinegard et al. 1985; Hassell et al.
1986). Indirect evidence for proteoglycan aggregates was
obtained from histochemical studies of chick marrow
where the high iron diamine-silver proteinate method
was used to stain chondroitinase-ABC-digestible material
in the marrow (Sorrell et al. 1987). Digestion of tissue
with Streptomyces hyaluronidase, which is known to
degrade hyaluronate specifically (Hay, 1981), resulted in
the loss of sulphated glycoconjugates, presumably chondroitin sulphates bound to hyaluronate. The presence of
hyaluronate in marrow and other haematopoietic tissues
is well documented (Olsson, 1971; Taniguchi et al. 1974;
Noordegraaf & Ploemacher, 1979, 1980; Noordegraaf et
al. 1981; Wight et al. 1986; Gordon et al. 1987; Oguri et
al. 1987). This does not mean that all marrow proteoglycans participate in macromolecular aggregates. On the
basis of inferences obtained from dot-blot analyses, the
middle and low buoyant density marrow proteoglycans
did not contain a hyaluronate binding region and consequently were unlikely to be capable of forming aggregates. If so, this would place the large core protein of the
proteoglycans of the middle buoyant density marrow and
cartilage fractions in the family of large non-aggregating
proteoglycans (Heinegard et al. 1985).
The occurrence of keratan sulphate proteoglycans in
marrow was unexpected, since chondroitin sulphate
proteoglycans containing keratan sulphate chains have
been considered exclusive to cartilage. Keratan sulphate
in the extracellular speces of chick marrow also has been
identified using immunocytochemical methods at the
electron-microscopic level (Sorrell et al. 1988). Recently,
keratan sulphate chains have been identified in tissues
other than cartilage and cornea. Circumstantial evidence
for its presence has been presented for aorta (Heinegard
& Hascall, 1979), and more recent immunocytochemical
evidence has been presented for its presence in developing conjunctiva (Sundarraj et al. 1986) and in the corpora
amylacea of the human brain (Liu et al. 1987). Funderburgh et al. (1987) have surveyed a variety of bovine and
chick non-cartilaginous tissues and have found that
keratan sulphate substitution is much more widespread
than anticipated. The function of keratan sulphatesubstituted proteoglycans in non-cartilaginous tissues,
including marrow, remains to be established.
Only one core protein, with an apparent molecular
weight of 120x10 , was identified in the cartilage low
buoyant density fraction. This proteoglycan has yet to be
positively identified, but it is possible that it represents
J. M. Sotrell et al.

PG-Lt described by Noro et al. (1983), which has
subsequently been renamed collagen type IX (Hassell et
al. 1986; Irwin & Mayne, 1986). Huber et al. (1986) have
estimated the size of this, minus the chondroitin sulphate
chain, at 115X103. If the 120X103 band proves to be
collagen type IX, then it is also probably present in
marrow.
The demonstration that there were apparent differences in the composition of chondroitin sulphate proteoglycan between marrow and cartilage may prove to be
significant. Chondroitin sulphates have been demonstrated to interact with some types of blood cells,
particularly lymphocytes, with a consequent modulation
fo some of their cellular functions (Darzynkiewicz &
Balazs, 1971; Siegel et al. 1987). Extracellular matrix
and/or components associated with matrix have been
shown to promote haematopoiesis either directly or
indirectly. Matrix derived from haematopoietic tissues,
but not other tissues, promotes the attachment of haematopoietic stromal cells to culture dishes and consequently
promotes growth and differentiation of haematopoietic
cells (Campbell et al. 1985). Similarly, bone marrow
matrix has been shown to alter the phenotypic expression
of HL-60 cells (Luikart et al. 1987). It is possible that
these functions are, at least in part, mediated by the
apparent ability of extracellular matrix components,
particularly proteoglycans, to sequester haematopoietic
growth factors (Okai, 1985; Gordon et al. 1987). The
implication to be drawn from these studies is that
haematopoietic-specific matrix components, probably
proteoglycans, may be involved in regulating haematopoiesis. If so, it should be possible to identify those
proteoglycans. The present study provides evidence that
some marrow chondroitin sulphate proteoglycans differ
from those found in cartilage. Whether these proteoglycans in marrow have functional roles in haematopoiesis
remains to be determined.
This work was supported by NIH grants CA4O059 and
AR32666.
References
BENTLEY, S. A. (1981). Close range cell:cell interaction required for
stem cell maintenance in continuous bone marrow culture. Expl
Heniat 9, 308-312.
BITTER, T. & Mum, H. M. (1962). A modified uronic acid carbazole
reaction. Analyt. Biochem. 4, 330-334.
CAMPBELL, A., WICHA, M. S. & LONG, M. (198S). Extracellular

matrix promotes the growth and differentiation of munne
hematopoietic cells in vitro. J. din. Invest. 75, 2085-2090.
CARNEY, S. L., BAYLISS, M. T., COLLIER, J. M. & MUIR, H. (1986).

Electrophorcsis of 35S-labeled protcoglycans on
polyacrylamide-agarose composite gels and their visualization by
fluorography. Analyt. Biochem. 156, 38-44.
CARRINO, D. A. & CAPLAN, A. I. (1985). Isolation and

characterization of proteoglycans synthesized in ovo by embryonic
chick cartilage and new bonc._7 biol. Chew. 260, 122-127.
CATERSON, B., CALABRO, T . , DONOHUE, P. J. & JAHNKE, M. R.

(1986). Monoclonal antibodies against cartilage proteoglycan and
link protein. In Articular Cartilage Biochemistry (ed. K.
Kuettner), pp. 59—73. New York: Raven Press.
CATERSON, B., CALABRO, T . & HAMPTON, A. (1987). Monoclonal

antibodies as probes for elucidating proteoglycans structure and

function. In Biology of Pmteoglycans (cd. R. P. Mccham & T. N.
Wight), pp. 1-26. New York: Academic Press.
CATERSON, B., CHRISTNER, J. E. & BAKER, J. R. (1983).

Identification of a monoclonal antibody that specifically recognizes
conical and skeletal keratan sulfate. Monoclonal antibodies to
cartilage protcoglycans.J. biol. Client. 258, 8848-8854.
CATERSON, B., CHRISTNER, J. E., BAKER, J. R. & COUCHMAN, J. R.

recognized by three monoclonal antibodies to keratan sulphate
involve sulphatcd hepta- or larger oligosacchandes of the poly (Nacetyllactosamme) series. Eur.J. Biochem. 157, 385-391.
MORT, J. S., CATERSON, B., POOLE, A. R. & ROUGHLEY, P. J.

(1985). The origin of human cartilage proteoglycan link-protein
heterogeneity and fragmentation during aging. Biochem. J. 232,
805-812.

(1985). Production and characterization of monoclonal antibodies
directed against connective tissue proteoglycans. Fedti Proc. Fedn
Am. Socs exp. Biol. 44, 386-393.
CURRY, J. L. & TRENTIN, J. J. (1967). Hemopoictic spleen colony
studies. I. Growth and differentiation. Devi Biol. 15, 395-413.

NOORDEGRAAF, E. M., ERKENS-VERSLUIS, E. A. & PLOEMACHER, R.

CURRY, J. L., TRENTIN, J. J. & WOLF, N. (1967). Hemopoietic

NOORDEGRAAF, E. M. & PLOEMACHER, R. E. (1979). Studies of the

spleen colony studies. II. Erythropoicsis. J. exp. Med. 125,
703-725.
DARZYNKIEWICZ, A. & BALAZS, E. (1971). Effect of connective tissue
intercellular matrix on lymphocyte stimulation. I. Suppression by
hyaluronic acid. Expl Cell Res. 66, 113-118.
DEXTER, T. M. (1982). Stromal cell associated haemopoiesis. J. cell.
Physio!. Suppl. I, 87-94.
DEXTER, T . M., ALLEN, T . D. & LAJTHA, L. G. (1977). Conditions

controlling the proliferation of hacmopoictic stem cells in vitro. J.
cell. Physio!. 91, 335-344.
FUNDERBURGH, J. L., CATERSON, B. & CONRAD, G. W. (1987).
Distribution of proteoglycans antigenically related to corneal
kcratan sulfate protcoglycan. 7- biol. Client. 262, 11 634-11 640.
GALLAGHER, J. T . , SPOONCER, E. & DEXTER, T . M. (1983). Role of

the cellular matrix in haemopoiesis. I. Synthesis of
glycosaminoglycans by mouse blue marrow cell culture. J. Cell Sci.
63, 155-171.
GORDON, M. Y., RILEY, G. P., WATT, S. M. & GREAVES, M. F.

(1987). Compartmentilization of a haematopoietic growth factor
(GM-CSF) by glycosaminoglycans in the bone marrow
microcnvironmcnt. Nature, Land. 326, 403-405.
HASCALL, V. C. & HASCALL, G. K. (1981). Proteoglycans. In
Biohfry of the Extracellular Matrix (ed. E. D. Hay), pp. 39-63.
New York: Plenum.
HASSELL, J. R., KIMURA, J. H. & HASCALL, V. C. (1986).

Protcoglycan core protein families. A. Rev. Biochem. 55, 539—567.
HAY, E. D. (1981). Extracellular matrix. J . Cell Biol. 91, 205s-233s.
HEINEGARD, D., BJORNE-PERSSON, A., COSTER, L., FRANZEN, A.,
GARDELL, S., MALMSTROM, A., PAULSSON, M., SANDFALK, R. &

VOGEL, K. (1985). The core proteins of large and small interstitial
proteoglycans from various connective tissues form distinct
subgroups. Biochem. J. 230, 181-194.
HEINEGARD, D. & HASCALL, V. C. (1979). Characteristics of the

nonaggregating proteoglycans isolated from bovine nasal cartilage.
J. biol. Chem. 254, 927-934.
HUBER, S., VAN DER REST, M., BRUCKNER, P., RODRIGUEZ, E.,
WINTERHALTER, K. H. & VAUGHAN, L. (1986). Identification of

the type IX collagen polypeptide chains. The a2(IX) polypeptide
carries the chondroitin sulfate chain(s).J. biol. Client. 261,
5965-5968.
IRWIN, M. H. & MAYNE, R. (1986). Use of monoclonal antibodies to
locate the chondroitin sulfate chain(s) in type IX collagen. J. biol.
Chem. 261, 16281-16283.
KIMATA, K., OKAYAMA, M., OOHIRA, A. & SUZUKI, S. (1974).

Heterogeneity of proteochondroitin sulfates produced by
chondrocytcs at different stages of cytodiffercntiation. J. biol.
Chem. 249, 1646-1653.
Liu, H. M., ANDERSON, K. & CATERSON, B. (1987). Demonstration

of a kcratan sulfate protcoglycan and a mannosc-rich
glycoconjugatc in corpora amylacca of the brain by
immunocytochcmical and lectin-binding methods. J. Neumimniun.
14, 49-60.
LUIKART, S. D., SACKRISON, J. L. & MANIGLIA, C. A. (1987). Bone

marrow matrix modulation of HL-60 phenotype. Blood 70,
1119-1123.
MCMURTREY, J., RADHAKRISHNAMURTHY, B., DALFERES, E. R.,

BERENSON, G. S. & GREGORY, J. D. (1979). Isolation of

protcoglycan—hyaluronatc complexes from bovine aorta. J'. biol.
Chem. 254, 1621-1626.
MEHMET, H., SCUDDER, P., TANG, P. W., HOUNSELL, E. F.,

CATERSON, B. & FEIZI, T . (1986). The antigenic determinants

E. (1981). Studies of the hemopoietic microenvironments: V.
Changes in murine splenic and bone marrow glycosaminoglycans
during post irradiation hemopoictic regeneration. Expl Hemat. 9,
326-331.
haemopoietic microcnvironment. II. Content of
glycosaminoglycans in murine bone marrow and spleen under
anaemic and polycythaemic conditions. Scand. J. Haemal. 22,
327-332.
NOORDEGRAAF, E. M. & PLOEMACHER, R. E. (1980). Studies of the

haemopoietic microenvironments. III. Glycosaminoglycan levels in
relation to phcnylhydrazine-induced erythropoiesis in the mouse
liver. Scand. J. Haemal. 24, 132-156.
NORLING, B., GLIMELIUS, B., WESTERMARK, B. & WASTESON, A.

(1978). A chondroitin sulphate proteoglycan from human cultured
glial cells aggregates with hyaluronic acid. Biochem. biophys. Res.
Commun. 84, 914-921.
NORO, A., KIMATA, K., OIKE, Y., SHINOMURA, T . , MAEDA, N.,
YANO, S., TAKAHASHI, N. & SUZUKI, S. (1983). Isolation and

characterization of a third proteoglycan (PG-Lt) from chick
embryo cartilage which contains disulfide-bonded collagcnous
polypeptide. 7. biol. Chem. 258, 9323-9331.
OEGEMA, T. R., HASCALL, V. C. & DZIEMIATKOWSKI, D. (1975).

Isolation and characterization of proteoglycans from the Swarm rat
chondrosarcoma.J. biol. Chem. 250, 6151-6159.
OGURI, K., OKAYAMA, E., CATERSON, B. & OKAYAMA, M. (1987).

Isolation, characterization and localization of glycosaminoglycans in
rabbit bone marrow. Blood 70, 501-510.
OKAI, Y. (1985). Large-molecular-weight thymocyte-activating
factors in extracellular matrix of SV-40-transformcd human embryo
fibroblasts. Immun. Lett. 11, 63-68.
OLSSON, I. (1971). Mucopolysaccharides of rabbit bone marrow cells.
Expl Cell. Res. 67, 416-426.
SAJDERA, S. W. & HASCALL, V. C. (1969). Protein-polysacchande

complex from bovine nasal cartilage. A comparison of low and high
extraction procedures. J. biol. Chem. 244, 77-87.
SCHAFER, I. A., SITABKHA, L. & PANDY, M. (1984). Isolation and

preliminary characterization of proteoglycan aggregates from
cultured dermal fibroblasts. J . 6/0/. Chem. 259, 2321-2330.
SHINOMURA, T., KIMATA, K., OIKE, Y., NORO, A., HIROSE, N.,

TANABE, K. & SUZUKI, S. (1983). The occurrence of three
different proteoglycan species in chick embryo cartilage. Isolation
and characterization of a second protcoglycan (PG-Lb) and its
precursor form. 7. biol. Chem. 258, 9314-9322.
SlEGEL, J. N., MALEMUD, C. J. & KAMMER, G. M. (1987). Intact
proteoglycan is a polyclonal activator of munnc B-lymphocytes.
Immun. Lett. 15, 127*-131.
SORRELL, J. M., MAHMOODIAN, F. & CATERSON, B. (1988).

Immunochemical characterization and ultrastructural localization
of chondroitin sulfates and kcratan sulfate in embryonic chick
marrow. Cell Tiss. Res. 252, 523-531.
SORRELL, J. M., Voci, M. & WEISS, L. (1987). Ultrastructural
localization of heparan sulfate and chondroitin sulfates associated
with granulopoiesis in embryonic chick bone marrow. AJII. J. Anal.
179, 186-197.
SPOONCER, E., GALLAGHER, J. T . , KRIZSA, F. & DEXTER, T . M.

(1983). Regulation of haemopoiesis in long-term bone marrow
cultures. IV. Glycosaminoglycan synthesis and the stimulation of
haemopoiesis by /3-D-xylosidcs.7. Cell Biol. 96, 510-514.
STEVENS, J. W., OIKE, Y., HANDLEY, C , HASCALL, V. C ,

HAMPTON, A. & CATERSON, B. (1984). Characteristics of the core
protein of the aggregating proteoglycan from the swarm rat
chondrosarcoma.7- cell. Biochem. 26, 247-259.
SUNDARRAJ, N., CHAO, J., GREGORY, J. D. & DAMLE, S. P. (1986).
Ocular distribution of kcratan sulfates during prc- and postnatal
development in rabbits. J. Histochem. Cytochem. 34, 971-976.

Chondroitin I dermatan sulphates m manvw

89

TANICUCHI, N., OKUDA, N. & NANBA, I. (1974). Characterization of

Chew. 258, 11 136-11 142.

glycosaminoglycans in rabbit plasma and leukocytes at disaccharide
subunit level. Biochem blophys. Ada 354, 130-138.
TRENTIN, J. J. (1978). Hemopoictic microenvironmcnts. Transplantn
Pmc. 10, 77-82.
VASAN, N. S. & LASH, J. W. (1978). Proteoglycan heterogeneity in
embryonic chick articular and cpiphyscal cartilages. Conn. Tiss.
Res. 6, 191-199.

WIGHT, T. N., KINSELLA, M. G., KEATING, A. & SINGER, J. W.

VLODAVSKY, I., FALKMAN, J., SULLIVAN, R., FRIDMAN, R., ISHAIMICHAELI, R., SASSE, J. & KLAGSBRUN, M. (1987). Endothelial

heterogeneity among stromal cell lines from mouse bone marrow
disclosed in their extracellular matrix composition and interactions
with normal and leukemic cells. Blood 66, 447-455.
ZUCKERMAN, K. S. & WICHA, M. S. (1983). Extracellular matrix
production by the adherent cells on long-term murine bone
marrow cultures. Blood 61, 540—547.

cell-derived basic fibroblastic growth factor: synthesis and
deposition into subcndothelial extracellular matrix. Proc. natn.

Acad. Sci. L'.SA. 84, 2292-22%.
WAGNER, \V. D., ROWE, H. A. & CONNOR, J. R. (1983).

Biochemical characteristics of dissociativcly isolated aortic
proteoglycans and their binding capacity to hyaluronic acid. J. biol.

90

J. M. Sorrell et al.

(1986). Proteoglycans m human long-term bone marrow cultures:
biochemical and ultrastructural analyses. Blood 67, 1333-1343.
WILLIAMS, N., JACKSON, H. & RABELLINO, E. M. (1977).

Proliferation and differentiation of normal granulopoietic cells in
continuous bone marrow cultures..'/, cell. Pliysiol. 93, 435-440.
ZIPORI, D., TOLEDO, J. & VON DER MARK, K. (1985). Phenotypic

(Received 27 January I9S6 -Accepted, in revised foivi, 2 June I9S8)

